CVRx, Inc. is a pioneering medical device company that focuses on developing innovative therapies to address a variety of cardiovascular conditions. The company's primary product is the Barostim Neo, a neuromodulation device designed to improve heart function by stimulating the body’s baroreceptors, which are essential for regulating blood pressure. CVRx aims to enhance the quality of life for patients with chronic heart failure and other cardiovascular diseases by offering this alternative treatment to traditional drug therapies. With a growing presence in the medical technology industry, CVRx, Inc. collaborates with healthcare providers and institutions worldwide to expand its reach and impact. Founded with a commitment to advancing patient care, the company plays a significant role in the cardiovascular segment, contributing to ongoing improvements in non-invasive treatment options. Headquartered in Minneapolis, Minnesota, CVRx continues to focus on research and development to further refine its technology and expand its product applications in the field of heart health management.